MDA-19

MDA-19

Systematic (IUPAC) name
(3Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide
Clinical data
Legal status	CA: Schedule II
Identifiers
CAS Number	1048973-47-2 N
PubChem	CID: 25034599
ChemSpider	24689676 N
Chemical data
Formula	C21H23N3O2
Molecular mass	349.426 g/mol
SMILES O=C(C1=CC=CC=C1)N/N=C(C2=CC=CC=C2N3CCCCCC)\C3=O
InChI InChI=1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14H,2-4,10,15H2,1H3,(H,23,25)/b22-19- N Key:ZGQHMZCITJHYOW-QOCHGBHMSA-N N
NY (what is this?)  (verify)

MDA-19 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB₂, with reasonable selectivity over the psychoactive CB₁ receptor, though with some variation between species. In animal studies it was effective for the treatment of neuropathic pain, but failed to produce cannabis-like behavioural effects.

See also

• AM-1221
• JTE 7-31
• JWH-019
• JWH-133
• N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-methoxyindole-3-carboxamide